Guided Therapeutics Inc.

Guided Therapeutics Inc. of Norcross, Ga., has submitted the preclinical module of its Premarket Approval application to the FDA for its LightTouch noninvasive cervical cancer detection device. The system analyzes reflected light wavelengths to detect biochemical and morphological changes at the cellular level, thereby locating cervical cancers. The clinical and manufacturing modules should be submitted this year.





LATEST NEWS

• IPG Names Industry Veteran Mark Gitin CEO
  Apr 30, 2024
• 16th Biannual Optatec Conference Continues in Frankfurt
  Apr 30, 2024
• Celestial Surface Mapping Tech Combines Established Techniques
  Apr 30, 2024
• TSMC Partnerships Target Integrated Photonics Capabilities
  Apr 30, 2024
• CLEO Heads to the East Coast
  Apr 29, 2024
• Laser-Based Gas Analyzer Developed to Detect Air Pollution
  Apr 29, 2024
• Qubits Could be Stored in Flash-Like Memory
  Apr 29, 2024
• Exail Signs LLNL Contract, Partners with Eelume
  Apr 26, 2024